By necessity New Zealanders are outward looking... well grounded but open to new ideas.

Investment New Zealand

   You are at: Home > Sector-by-Sector Guide > Biotechnology > Our Investment Specialists

Michelle Sullivan

Michelle SullivanInvestment Manager - Biotechnology

Michelle Sullivan joined Investment New Zealand in April 2003 to focus on attracting investment to New Zealand's biotechnology sector.

She has worked in investment in London and New York, covering a range of different sectors including specialised manufacturing and wood processing. Michelle joined the Investment New Zealand food and beverage team as investment manager in August 2004 and was appointed to the biotechnology team in October 2005. She is experienced in assisting companies with their New Zealand investment strategies.

Background and expertise

Michelle has a Bachelor of Science (Hons) in biochemistry from the University of Otago, and a PhD in biochemistry from Massey University, New Zealand.

She has previously worked as an environmental consultant with Waste Not Limited, and also as a programme manager for the Health Research Council of New Zealand.

The Health Research Council project was to develop a NZ$1.2m-plus air quality research fund between the Council, Ministry for the Environment, Ministry of Transport, Ministry of Health, Environment Canterbury and Auckland Regional Council.

Other cross-sectoral research initiatives Michelle has managed include the immunisation, problem gambling, Maori health and occupational health and safety projects under the 'partnership programme' umbrella.

Other Sector Specialists

Creative Industries - Screen Production

Information & Communications Technology

Food & Beverage

Specialised Manufacturing

Wood Processing



Contact Michelle Sullivan

Office: Auckland

Country: New Zealand

Phone: +64 9 366 4768

Click here to send an online enquiry





Biotechnology Sector Case Studies

BioPacificVentures

BioPacificVentures, Australasia’s biggest life sciences venture capital fund, was launched in March 2005. The NZ$150 million fund is a partnership between New Zealand and Swiss venture capital managers.